Endologix Seeks Sanctions For Investor's Witness Statements
By Rachel Graf ( July 24, 2017, 1:54 PM EDT) -- Endologix Inc. urged a California federal judge Friday to sanction a shareholder whose amended complaint allegedly hinges on false statements made by a single witness in a proposed class action claiming the medical device maker misrepresented the likelihood that a product would be approved by the U.S. Food and Drug Administration, causing its stock to plunge....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.